The Biden administration said Thursday that children under 5 may be able to get their first COVID-19 vaccination doses as soon as June 21, if federal regulators authorize shots for the age group, as expected.
Jun 2, 2022
0
1
A 35-ton shipment of hypoallergenic baby formula from Switzerland arrived in the United States on Sunday, the first delivery in what the Biden administration is calling "Operation Fly Formula" to deal with a nationwide shortage.
May 23, 2022
0
17
Many parents are hunting for infant formula because of a combination of short- and long-term problems that has hit most of the biggest U.S. brands.
May 12, 2022
0
13
Perhaps you stocked up when at-home COVID-19 test kits were hard to come by, before the U.S. federal government started a program to mail some to each household. Or maybe you found a bunch of test kits for a good price at ...
May 10, 2022
0
33
President Joe Biden's administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid, seeking to reassure doctors that there is ample supply for people at high risk of severe ...
Apr 26, 2022
0
5
President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed.
Apr 23, 2022
0
28
Outlining a daunting timeline for development of any updated COVID-19 vaccine for next fall, federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin ...
Apr 8, 2022
0
2
The COVID-19 treatment remdesivir dominated hospital drug spending in 2021, accounting for nearly 10% of all pharmaceutical expenses and outpacing the next three drugs combined, according to the National Trends in Prescription ...
Apr 6, 2022
0
15
An advisory panel to the U.S. Food and Drug Administration will meet Wednesday to discuss the best way forward with coronavirus vaccines, as evidence grows that variants are eroding the power of the country's current shots.
Apr 6, 2022
0
14
GlaxoSmithKline's IV drug for COVID-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most U.S. cases, federal health regulators said Tuesday.
Apr 5, 2022
0
4
